clonidine and losartan potassium

clonidine has been researched along with losartan potassium in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Díez, JJ; Gómez-Pan, A; Iglesias, P; Méndez, J; Romero, JR; Sastre, J; Selgas, R	1
Díez, J; Gómez-Pan, A; Iglesias, P; Méndez, J; Sastre, J; Selgas, R	1
Aguilera, A; Bajo, MA; Díez, JJ; Gómez Pan, A; Iglesias, P; Méndez, J; Sastre, J; Selgas, R	1

Trials

2 trial(s) available for clonidine and losartan potassium

Article	Year
Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients. Nephron, 1996, Volume: 74, Issue:3 Topics: Adrenergic alpha-Agonists; Adult; Aged; Anemia; Clonidine; Erythropoietin; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamus; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Stimulation, Chemical; Uremia	1996
Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis. Metabolism: clinical and experimental, 1999, Volume: 48, Issue:2 Topics: Adrenergic alpha-Agonists; Adult; Aged; Clonidine; Erythropoietin; Female; Hormones; Human Growth Hormone; Humans; Insulin; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Uremia	1999

Article

Year

Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.

Nephron, 1996, Volume: 74, Issue:3

Topics: Adrenergic alpha-Agonists; Adult; Aged; Anemia; Clonidine; Erythropoietin; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamus; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Stimulation, Chemical; Uremia

1996

Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.

Metabolism: clinical and experimental, 1999, Volume: 48, Issue:2

Topics: Adrenergic alpha-Agonists; Adult; Aged; Clonidine; Erythropoietin; Female; Hormones; Human Growth Hormone; Humans; Insulin; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Uremia

1999

Other Studies

1 other study(ies) available for clonidine and losartan potassium

Article	Year
Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1992, Volume: 8 Topics: Adolescent; Adult; Clonidine; Erythropoietin; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pituitary Function Tests; Recombinant Proteins	1992

Article

Year

Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1992, Volume: 8

Topics: Adolescent; Adult; Clonidine; Erythropoietin; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pituitary Function Tests; Recombinant Proteins

1992